Dr. John Hajjar, MD

NPI: 1104894435
Total Payments
$8,632
2024 Payments
$1,208
Companies
20
Transactions
68
Medicare Patients
4,180
Medicare Billing
$408,361

Payment Breakdown by Category

Other$5,070 (58.7%)
Gifts$1,960 (22.7%)
Food & Beverage$1,352 (15.7%)
Education$250.35 (2.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Debt forgiveness $4,470 5 51.8%
Gift $1,960 1 22.7%
Food and Beverage $1,352 58 15.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $600.00 1 7.0%
Education $250.35 3 2.9%

Top Paying Companies

Company Total Records Latest Year
Olympus America Inc. $4,560 8 $0 (2024)
Allergan, Inc. $1,960 1 $0 (2020)
Abbott Laboratories $600.00 1 $0 (2018)
Astellas Pharma US Inc $328.56 7 $0 (2023)
Smith & Nephew, Inc. $208.91 2 $0 (2018)
Bayer Healthcare Pharmaceuticals Inc. $196.22 9 $0 (2024)
Sumitomo Pharma America, Inc. $183.57 12 $0 (2024)
Antares Pharma, Inc. $121.65 8 $0 (2024)
AstraZeneca Pharmaceuticals LP $117.19 1 $0 (2019)
Axonics, Inc. $92.66 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,208 23 Olympus America Inc. ($858.78)
2023 $4,166 23 Olympus America Inc. ($3,612)
2022 $294.75 14 Astellas Pharma US Inc ($116.72)
2021 $14.43 1 Teleflex LLC ($14.43)
2020 $1,973 2 Allergan, Inc. ($1,960)
2019 $117.19 1 AstraZeneca Pharmaceuticals LP ($117.19)
2018 $765.13 3 Abbott Laboratories ($600.00)
2017 $93.33 1 Smith & Nephew, Inc. ($93.33)

All Payment Transactions

68 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/12/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $14.99 General
Category: NEPHROLOGY
11/18/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $14.11 General
Category: TESTOSTERONE REPLACEMENT THERAPY
11/14/2024 Janssen Biotech, Inc. ERLEADA (Drug) Food and Beverage In-kind items and services $17.09 General
Category: Oncology
11/13/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $13.85 General
Category: UROLOGY
11/11/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $17.03 General
Category: UROLOGY
09/26/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $28.33 General
Category: Oncology
09/26/2024 Janssen Biotech, Inc. ERLEADA (Drug) Food and Beverage In-kind items and services $19.81 General
Category: Oncology
09/23/2024 Tolmar, Inc. ELIGARD (Drug), JATENZO Food and Beverage Cash or cash equivalent $18.44 General
Category: ONCOLOGY
09/17/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $15.67 General
Category: UROLOGY
07/01/2024 Axonics, Inc. Axonics (Device) Food and Beverage In-kind items and services $19.62 General
Category: Urology
06/28/2024 Olympus America Inc. Olympus (Device) Debt forgiveness In-kind items and services $3.29 General
Category: Endotherapy
06/26/2024 Janssen Biotech, Inc. ERLEADA (Drug) Food and Beverage In-kind items and services $14.77 General
Category: Oncology
06/14/2024 Axonics, Inc. Axonics (Device) Food and Beverage In-kind items and services $24.34 General
Category: Urology
06/06/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $30.67 General
Category: Oncology
05/29/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $13.97 General
Category: UROLOGY
05/17/2024 Janssen Biotech, Inc. ERLEADA (Drug), AKEEGA Food and Beverage In-kind items and services $20.58 General
Category: Oncology
05/06/2024 Olympus America Inc. Debt forgiveness In-kind items and services $0.10 General
03/28/2024 Olympus America Inc. Debt forgiveness In-kind items and services $823.50 General
03/28/2024 Olympus America Inc. Debt forgiveness In-kind items and services $31.89 General
03/27/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $15.02 General
Category: Oncology
03/20/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $15.44 General
Category: UROLOGY
02/09/2024 Axonics, Inc. Axonics (Device) Food and Beverage In-kind items and services $20.47 General
Category: Urology
02/07/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $15.10 General
Category: UROLOGY
12/13/2023 Supernus Pharmaceuticals, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $16.35 General
Category: TESTOSTERONE REPLACEMENT THERAPY
11/13/2023 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $16.90 General
Category: Urology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 1,584 2,727 $737,858 $153,077
2022 18 1,017 1,556 $442,736 $109,238
2021 16 1,147 1,881 $470,332 $118,320
2020 10 432 515 $102,857 $27,726
Total Patients
4,180
Total Services
6,679
Medicare Billing
$408,361
Procedure Codes
65

All Medicare Procedures & Services

65 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 257 690 $201,697 $49,949 24.8%
76872 Ultrasound scan of pelvic region through rectum Office 2023 140 163 $79,213 $18,941 23.9%
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2023 16 106 $77,211 $14,198 18.4%
76856 Complete ultrasound scan of pelvis Office 2023 118 156 $58,096 $13,925 24.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 104 118 $49,531 $11,788 23.8%
76770 Complete ultrasound scan behind abdominal cavity Office 2023 83 109 $41,808 $10,150 24.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 76 76 $41,876 $9,009 21.5%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 65 90 $27,380 $6,910 25.2%
52224 Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm Facility 2023 23 25 $69,325 $4,260 6.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 49 49 $18,091 $3,961 21.9%
81002 Urinalysis, manual test Office 2023 300 685 $9,590 $2,330 24.3%
51798 Ultrasound measurement of bladder capacity after voiding Office 2023 166 191 $7,125 $1,857 26.1%
55700 Biopsy of prostate gland Facility 2023 12 12 $9,966 $1,099 11.0%
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle Office 2023 16 33 $3,865 $1,025 26.5%
36415 Insertion of needle into vein for collection of blood sample Office 2023 94 114 $3,420 $907.20 26.5%
72194 Ct scan of pelvis before and after contrast Office 2023 17 17 $14,666 $795.04 5.4%
52000 Diagnostic exam of bladder and urethra using an endoscope Facility 2023 13 14 $11,699 $783.38 6.7%
96372 Injection of drug or substance under skin or into muscle Office 2023 11 55 $2,631 $655.20 24.9%
76872 Ultrasound scan of pelvic region through rectum Facility 2023 12 12 $7,088 $274.50 3.9%
76942 Ultrasonic guidance for needle placement Facility 2023 12 12 $3,582 $258.40 7.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 210 488 $120,194 $36,075 30.0%
76872 Ultrasound scan of pelvic region through rectum Office 2022 144 180 $88,086 $22,122 25.1%
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2022 15 108 $78,668 $14,302 18.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 68 79 $28,146 $7,605 27.0%
76770 Complete ultrasound scan behind abdominal cavity Office 2022 56 70 $26,739 $6,738 25.2%

About Dr. John Hajjar, MD

Dr. John Hajjar, MD is a Urology healthcare provider based in Jersey City, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104894435.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Hajjar, MD has received a total of $8,632 in payments from pharmaceutical and medical device companies, with $1,208 received in 2024. These payments were reported across 68 transactions from 20 companies. The most common payment nature is "Debt forgiveness" ($4,470).

As a Medicare-enrolled provider, Hajjar has provided services to 4,180 Medicare beneficiaries, totaling 6,679 services with total Medicare billing of $408,361. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Location Jersey City, NJ
  • Active Since 03/11/2006
  • Last Updated 07/03/2025
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1104894435

Products in Payments

  • EVIS EXERA lll COLONOVIDEOSCOPE (Device) $3,612
  • ALLODERM (Device) $1,960
  • Nubeqa (Drug) $196.22
  • GEMTESA (Drug) $183.57
  • FARXIGA (Drug) $117.19
  • LENS Surgical Imaging System (Device) $115.58
  • NOCDURNA (Drug) $107.54
  • Journey II CR (Device) $93.33
  • Axonics (Device) $92.66
  • Myrbetriq (Drug) $78.21
  • ERLEADA (Drug) $72.25
  • EVIS EXERA (Device) $49.55
  • iTIND System (Device) $40.43
  • XYOSTED (Drug) $30.46
  • Natesto (Drug) $25.77
  • ELIGARD (Drug) $18.44
  • TLANDO (Drug) $15.62
  • JYNARQUE (Drug) $14.99
  • UroLift System (Device) $14.43
  • AVEED (Biological) $13.89

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Jersey City